BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cosola C, Rocchetti MT, di Bari I, Acquaviva PM, Maranzano V, Corciulo S, Di Ciaula A, Di Palo DM, La Forgia FM, Fontana S, De Angelis M, Portincasa P, Gesualdo L. An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. Toxins (Basel) 2021;13:334. [PMID: 34063068 DOI: 10.3390/toxins13050334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Lydia A, Indra TA, Rizka A, Abdullah M. The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02890-9] [Reference Citation Analysis]
2 Bartochowski P, Gayrard N, Bornes S, Druart C, Argilés A, Cordaillat-simmons M, Duranton F. Gut–Kidney Axis Investigations in Animal Models of Chronic Kidney Disease. Toxins 2022;14:626. [DOI: 10.3390/toxins14090626] [Reference Citation Analysis]
3 Rocchetti MT, Russo P, Spano G, De Santis L, Iarusso I, De Simone N, Brahimi S, Fiocco D, Capozzi V. Exploring the Probiotic Potential of Dairy Industrial-Relevant Lactobacilli. Applied Sciences 2022;12:4989. [DOI: 10.3390/app12104989] [Reference Citation Analysis]
4 De Mauri A, Carrera D, Bagnati M, Rolla R, Vidali M, Chiarinotti D, Pane M, Amoruso A, Del Piano M. Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial. Nutrients 2022;14:1637. [PMID: 35458199 DOI: 10.3390/nu14081637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zaidan N, Nazzal L. The Microbiome and Uremic Solutes. Toxins 2022;14:245. [DOI: 10.3390/toxins14040245] [Reference Citation Analysis]
6 Kocot AM, Jarocka-Cyrta E, Drabińska N. Overview of the Importance of Biotics in Gut Barrier Integrity. Int J Mol Sci 2022;23:2896. [PMID: 35270039 DOI: 10.3390/ijms23052896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen L, Shi J, Ma X, Shi D, Qu H. Effects of Microbiota-driven Therapy on Circulating Indoxyl Sulfate and P-cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr 2021:nmab149. [PMID: 34905018 DOI: 10.1093/advances/nmab149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rocchetti MT. New Strategies for the Reduction of Uremic Toxins: How Much More We Know. Toxins (Basel) 2021;13:837. [PMID: 34941675 DOI: 10.3390/toxins13120837] [Reference Citation Analysis]
9 Monteiro RC, Berthelot L. Role of gut-kidney axis in renal diseases and IgA nephropathy. Curr Opin Gastroenterol 2021;37:565-71. [PMID: 34482323 DOI: 10.1097/MOG.0000000000000789] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Mafra D, Kalantar-Zadeh K, Moore LW. New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD. J Ren Nutr 2021;31:433-7. [PMID: 34294553 DOI: 10.1053/j.jrn.2021.07.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]